Compounds > carvedilol

carvedilol and guanylyl imidodiphosphate

carvedilol has been researched along with guanylyl imidodiphosphate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristow, MR; Handwerger, D; Klein, J; Larrabee, P; Minobe, W; Müller-Beckmann, B; Port, JD; Roden, R; Skerl, L1
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Maack, C; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH; Zolk, O1
Böhm, M; Cremers, B; Flesch, M; Höper, A; Maack, C; Südkamp, M1
Böhm, M; Cremers, B; Ettelbrück, S; Flesch, M; Maack, C; Rosenkranz, S; Schlüter, KD; Zolk, O1
Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH1

Other Studies

5 other study(ies) available for carvedilol and guanylyl imidodiphosphate

ArticleYear
Receptor pharmacology of carvedilol in the human heart.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 1

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cyclic AMP; Guanylyl Imidodiphosphate; Humans; Iodocyanopindolol; Metoprolol; Myocardium; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents

1992
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
    Cardiovascular research, 1998, Volume: 40, Issue:1

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Genetically Modified; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Colforsin; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Guanylyl Imidodiphosphate; Heart Rate; Isoproterenol; Male; Neuropeptide Y; Pertussis Toxin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Virulence Factors, Bordetella

1998
Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium.
    British journal of pharmacology, 2000, Volume: 130, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Carvedilol; Catecholamines; Female; Guanylyl Imidodiphosphate; Heart Failure; Humans; In Vitro Techniques; Iodocyanopindolol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Propanolamines

2000
Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Cardiovascular research, 2001, Feb-01, Volume: 49, Issue:2

    Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Cell Size; Cells, Cultured; Electric Stimulation; Guanylyl Imidodiphosphate; Isoproterenol; Male; Metoprolol; Microscopy, Phase-Contrast; Myocardium; Propanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Regression Analysis

2001
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    British journal of pharmacology, 2001, Volume: 133, Issue:8

    Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics

2001